Detalhe da pesquisa
1.
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Int J Cancer
; 154(6): 1043-1056, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994647
2.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972660
3.
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial.
Hepatology
; 77(5): 1540-1549, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070950
4.
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study.
Liver Int
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38618972
5.
Systemic Delivery of a STING Agonist-Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis.
Small
; 19(43): e2300544, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381624
6.
Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
Oncology
; 101(5): 283-291, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657420
7.
Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients.
Cancer
; 128(5): 995-1003, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878659
8.
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma.
Liver Int
; 42(3): 674-681, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34792284
9.
Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenib.
Future Oncol
; 18(27): 3021-3030, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35903991
10.
A prospective, multicenter, open-label study of the clinical efficacy of tapentadol extended-release in the treatment of cancer-related pain and improvement in the quality of life of opioid-naïve or opioid-resistant patients.
Support Care Cancer
; 30(7): 6103-6112, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35420330
11.
Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1.
Gene Ther
; 28(3-4): 186-198, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33149278
12.
Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma.
J Hepatol
; 74(2): 350-359, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810553
13.
Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors.
Int J Mol Sci
; 22(17)2021 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34502325
14.
Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach.
Int J Mol Sci
; 22(15)2021 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34360800
15.
Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study.
Liver Int
; 40(10): 2544-2552, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32563213
16.
Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors.
Int J Mol Sci
; 21(20)2020 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33086754
17.
The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer.
Gastric Cancer
; 22(1): 113-122, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29948387
18.
Risk of Variceal Bleeding in Patients With Advanced Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab.
Clin Gastroenterol Hepatol
; 21(9): 2421-2423.e2, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944830
19.
Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.
Ann Surg
; 265(5): 946-953, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27232252
20.
Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients.
BMC Cancer
; 16: 385, 2016 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27377907